Hepatitis B vaccination and multiple sclerosis;Vaccination contre l'hépatite B et sclérose en plaques

Presse Medicale

Volumn 34, Issue 17, 2005, Pages 1205-1208

  Confavreux, Christian ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

EDITORIAL; HEPATITIS B; HUMAN; MULTIPLE SCLEROSIS; VACCINATION;

EID: 26844452902     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0755-4982(05)84157-0     Document Type: Editorial

References (17)

1. Gout O, Théodorou I, Liblau R, Lyon-Caen O. Central nervous system demyelination after recombinant hepatitis B vaccination: report of 25 cases. Neurology 1997; 48 (Suppl): A424.
2. Tourbah A, Gout O, Liblau R, Lyon-Caen O, Bougniot C, Iba-Zizen MT et al. Encephalitis after hepatitis B vaccination: recurrent disseminated encephalitis or MS? Neurology 1999; 53: 396-401.
3. Fourrier A, Touzé E, Alpérovitch A, Bégaud B. Association between hepatitis B vaccine and multiple sclerosis: a case-control study. Pharmacoepidemiol Drug Saf 1999; 8 (Suppl): S140-S141.
4. Sturkenboom MCJM, Abenhaim L, Wolfson C, Roullet E, Heinzlef O, Gout O. Vaccinations, demyelination and multiple sclerosis study (VDAMS). A population-based study in the UK. Pharmacoepidemiol Drug Saf 1999; 8 (Suppl): S170-S171.
5. Sturkenboom MC, Wolfson C, Roullet E, Heinzlef O, Abenhaim L. Demyelination, multiple sclerosis, and hepatitis B vaccination: a population-based study in the UK. Neurology 2000; 54 (Suppl 3): A166.
6. Touzé E, Gout O, Verdier-Taillefer MH, Lyon-Caen O, Alperovitch A. Premier épisode de démyélinisation du système nerveux central et vaccination contre l'hépatite B. Étude cas-témoins pilote. Rev Neurol 2000; 156: 242-6.
7. Touzé E, Fourrier A, Rue-Fenouche C, Ronde-Oustau V, Jeantaud I, Begaud B et al. Hepatitis B vaccination and first central nervous system demyelinating event: a case-control study. Neuroepidemiology 2002; 21: 180-6.
8. Zipp F, Weil JG, Einhaupl KM. No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 1999; 5: 964-5.
9. Sadovnick AD, Scheifele DW. School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet 2000; 355: 549-50.
10. Ascherio A, Zhang SM, Hernan MA, Olek M, Coplan P, Brodovicz K. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 334: 327-32.
11. DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB et al. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 2003; 60: 504-9.
12. Confavreux C, Suissa S, Saddier P, Bourdes V, Vukusic S. Vaccines in Multiple Sclerosis Study Group. Vaccinations and the risk of relapse in multiple sclerosis. N Engl J Med 2001; 344: 319-26.
13. Hernan MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis. A prospective study. Neurology 2004; 63: 838-42.
14. Gran B, Bielekova B, McFarland H, Martin R. Development of multiple sclerosis after hepatitis B vaccination: an immunologic case report. Neurology 2000; 54 (suppl 3): A164.
15. th Edition). Compston DAS ed. Elsevier, London (in press).
16. Naismith RT, Cross AH. Does the hepatitis B vaccine cause multiple sclerosis? Neurology 2004; 63: 772-3.
17. Poland GA, Jacobson RM. Prevention of hepatitis B with the hepatitis B vaccine. N Engl J Med 2004; 351: 2832-8.